Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.
Saved in:
| Title: | Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial. |
|---|---|
| Authors: | Rediti M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Fimereli D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Mileva M; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., Wimana Z; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., Venet D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Flamen P; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., Guiot T; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC location VUMC, Cancer Centre Amsterdam, Amsterdam, the Netherlands., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Majjaj S; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Larsimont D; Department of Pathology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Gebhart G; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 110-121. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39470686 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rediti+M%22">Rediti M</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Fimereli+D%22">Fimereli D</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Mileva+M%22">Mileva M</searchLink>; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Wimana+Z%22">Wimana Z</searchLink>; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Venet+D%22">Venet D</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Flamen+P%22">Flamen P</searchLink>; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Guiot+T%22">Guiot T</searchLink>; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22de+Vries+EGE%22">de Vries EGE</searchLink>; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schröder+CP%22">Schröder CP</searchLink>; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Menke-van+der+Houven+van+Oordt+CW%22">Menke-van der Houven van Oordt CW</searchLink>; Department of Medical Oncology, Amsterdam UMC location VUMC, Cancer Centre Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Maetens+M%22">Maetens M</searchLink>; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Majjaj+S%22">Majjaj S</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Larsimont+D%22">Larsimont D</searchLink>; Department of Pathology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Rothé+F%22">Rothé F</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Sotiriou+C%22">Sotiriou C</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gebhart+G%22">Gebhart G</searchLink>; Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 110-121. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39470686 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-24-1007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 110 Titles: – TitleFull: Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rediti M – PersonEntity: Name: NameFull: Fimereli D – PersonEntity: Name: NameFull: Mileva M – PersonEntity: Name: NameFull: Wimana Z – PersonEntity: Name: NameFull: Venet D – PersonEntity: Name: NameFull: Flamen P – PersonEntity: Name: NameFull: Guiot T – PersonEntity: Name: NameFull: de Vries EGE – PersonEntity: Name: NameFull: Schröder CP – PersonEntity: Name: NameFull: Menke-van der Houven van Oordt CW – PersonEntity: Name: NameFull: Maetens M – PersonEntity: Name: NameFull: Majjaj S – PersonEntity: Name: NameFull: Larsimont D – PersonEntity: Name: NameFull: Rothé F – PersonEntity: Name: NameFull: Sotiriou C – PersonEntity: Name: NameFull: Gebhart G IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 01 Text: 2025 Jan 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 31 – Type: issue Value: 1 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |
